Patient, activist, and lobbyist, Miss Stewart uses her experience as a patient to serve as a public policy advocate for chronic pain patients. She has an unusually high success rate in enacting legislation at the state and federal level. Recently she advocated for patient centric policies at the CDC.
To learn more about her work, please see the following link.
She can be found on twitter at following link.
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
